LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
-2.99%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(-26%)
Cap. Flow
-$39.8M
Cap. Flow
% of AUM
-15.27%
Top 10 Holdings %
Top 10 Hldgs %
50.97%
Holding
59
New
21
Increased
10
Reduced
8
Closed
19
Top Buys
| 1 |
AbbVie
ABBV
|
$20.2M |
| 2 |
Moderna
MRNA
|
$13.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
$10.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.5M |
| 5 |
Passage Bio
PASG
|
$8.96M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$20.6M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$18M |
| 3 |
BLUE
bluebird bio
BLUE
|
$17.9M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$15.9M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$14.2M |
Sector Composition
| 1 | Healthcare | 93.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
uniQure
QURE
$896M
| – | – |
-138,425
| Closed | -$9.92M |
|
|
SWTX
52
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-134,397
| Closed | -$5.17M |
|
|
ISEE
53
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-523,462
| Closed | -$4.49M |
|
|
APTO
54
DELISTED
Aptose Biosciences, Inc.
APTO
| – | – |
-523,803
| Closed | -$2.97M |
|
|
CCXI
55
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-186,238
| Closed | -$7.37M |
|
|
XLRN
56
DELISTED
Acceleron Pharma Inc.
XLRN
| – | – |
-267,676
| Closed | -$14.2M |
|
|
KDMN
57
DELISTED
Kadmon Holdings, Inc.
KDMN
| – | – |
-1,350,351
| Closed | -$6.12M |
|
|
CNST
58
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-101,050
| Closed | -$4.76M |
|
|
BHVN
59
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-187,242
| Closed | -$10.2M |
|